WASHINGTON—Primary care providers agree, almost unanimously, that family caregivers play a vital role in patient care and in better patient outcomes, according to a new survey by AARP Research.

WASHINGTON, DC—AARP CEO Jo Ann Jenkins released the following statement in response to the State of the Union address this evening: “In tonight’s State of the Union address, AARP was...

WASHINGTON, DC—Today AARP National Volunteer President Dr. Catherine Alicia Georges, EdD, RN, testified on Capitol Hill at the U.S. House Committee on Oversight and Reform about the impact of...

WASHINGTON, DC—The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on yesterday’s court ruling in Texas v. United States:...

WASHINGTON, DC—Today AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond released the following statement on Congress passing the Agriculture Improvement Act of 2018 (H.R. 2):

Today, AARP announced the launch of a major new advocacy campaign urging Congress to stand up to the pharmaceutical industry and protect seniors from any attempts to raise patient drug costs by...

WASHINGTON, DC—A positive sense of mental well-being is related to better brain health among older adults, according to a new report issued today by the Global Council on Brain Health (GCBH). Research shows our sense of mental well-being tends to increase after middle age and there are steps we can take to help improve it, regardless of age.

WASHINGTON, DC—AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond released the following statement in response to Senate passage of the bipartisan SUPPORT for Patients and Communities Act:

WASHINGTON, DC—Retail prices for many of the most commonly-used brand name drugs by older adults rocketed upward by an average of 8.4 percent in 2017, outstripping the general inflation rate of 2.1 percent. The annual average cost of therapy for just one brand name drug increased to almost $6,800 in 2017.

WASHINGTON, DC—AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond released the following statement in response to lobbying efforts by PhRMA to change the Medicare Part D doughnut hole deal